DE
|
23-3012204
|
|
(State or other jurisdiction of
|
(IRS Employer
|
|
incorporation)
|
Identification No.)
|
On November 1, 2012, Nutrisystem, Inc. (the "Company") entered into an Employment Letter Agreement (the "Letter Agreement") with Dawn Zier, pursuant to which she will become the President and Chief Executive Officer of the Company on November 15, 2012. The Company's Board of Directors (the "Board") elected Ms. Zier to the Board effective as of November 15, 2012, which is the date of the commencement of Ms. Zier's employment with the Company. Ms. Zier will be filling the Board vacancy created by the departure of Joseph R. Redling, the Company's current President and Chief Executive Officer, on November 9, 2012.
Consistent with the objectives stated in the Company's 2012 annual meeting proxy statement, Ms. Zier's employment terms are intended to reflect the Company's reformed compensation practices and her target total direct compensation ("TDC") (i.e., the sum of base salary, target bonus plus grant date fair value of annual equity awards) is intended to approximate benchmark medians.
The following is a brief description of the Company's Letter Agreement with Ms. Zier:
Annual Compensation. Ms. Zier's base salary will be $600,000 and will be subject to annual review. Commencing with the 2013 calendar year, she will be eligible for a performance-based annual bonus with a target amount of $500,000 (or, if greater in future years, 75% of her then current base salary). Because certain key events and decisions impacting 2013 performance have already occurred, the Company has agreed that Ms. Zier's minimum bonus for 2013 will be $250,000. Ms. Zier will not be eligible for an annual bonus for the 2012 calendar year and no minimum bonus is guaranteed for years after 2013.
On the date the Company grants annual equity awards to its other executive officers in 2013, Ms. Zier will then receive an equity grant with a grant date fair value of $850,000, the amount required for her TDC to approximate benchmark medians. The terms of such grant will be consistent with those approved for other executives. After this 2013 annual grant, any future equity awards will be solely in the discretion of the Compensation Committee of the Board.
For the first two years of Ms. Zier's tenure, she will receive a temporary housing and transportation allowance of $4,167 per month. The Company agreed to provide this benefit for two years to enable Ms. Zier's children to remain in their existing school during what was agreed was a critical time in their education.
Replacement Awards. As a result of accepting employment with us, it is expected that Ms. Zier will forego cash compensation from her existing employer of approximately $1.3 million. To attract her to the Company, it was necessary to compensate her for this foregone compensation. Accordingly, the Company agreed to award Ms. Zier $500,000 in cash and $800,000 in restricted stock upon commencement of her employment. These awards will be forfeited by her if she voluntarily resigns from employment before the earlier of a change in control and the second anniversary of her hire.
Inducement Award. To further induce her to accept the Company's offer of employment and to immediately align her interests with those of the Company's stockholders, upon commencement of her employment the Company will award to Ms. Zier (i) stock options with a grant date fair value of $300,000 that vest ratably over four years, and (ii) performance-based restricted stock units ("PRSUs") with a grant date value fair of $300,000 that vest based on the Company's total shareholder return relative to that of the Russell 3000 index over the three year period commencing January 1, 2013.
Severance. If Ms. Zier's employment with the Company ceases due either to a termination of her employment by the Company without cause or by her for good reason, then subject to her execution of a release and compliance with her restrictive covenant obligations, Ms. Zier will receive (i) continuation of her base salary for two years, (ii) continuation of group health coverage for 18 months, (iii) a pro-rata portion of her annual bonus for the year of termination, (iv) her 2013 minimum annual bonus, to the extent not already paid or payable, (v) accelerated vesting of her replacement cash and stock awards and her inducement stock option award, and (vi) a pro-rata portion of her inducement PRSUs, based on actual corporate performance through the end of the performance period.
During her employment and for two years following any termination, Ms. Zier will be subject to customary non-competition and non-solicitation covenants. In addition, the Company has also agreed to provide Ms. Zier with customary indemnification rights for claims arising against her in her capacity as an officer or director of the Company.
The description of the Letter Agreement herein does not purport to be complete and is qualified in its entirety by reference to the Letter Agreement, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference. Award agreements for the equity grants that will be made to Ms. Zier upon her commencement of employment are filed as Exhibits 10.2, 10.3 and 10.4, respectively, to this Current Report on Form 8-K and are incorporated herein by reference.
The Company issued a press release on November 5, 2012 announcing, among other things, the hiring of Ms. Zier, which is attached as Exhibit 99.1 to this Current Report on Form 8-K.
Extension of Current President and Chief Executive Officer
As previously disclosed, on April 4, 2012, the Company entered into a letter agreement (the "Agreement") with Joseph M. Redling, the Company's President and Chief Executive Officer and a member of the Company's Board of Directors, pursuant to which it was contemplated that Mr. Redling's employment with the Company would cease on September 30, 2012 or such earlier date requested by the Company on 15 days prior written notice (the "Cessation Date"). As previously disclosed, on September 27, 2012 the Cessation Date was extended by an amendment (the "First Amendment") to November 2, 2012 or such earlier date requested by the Company on 15 days prior written notice. On November 1, 2012, the Cessation Date was extended further by an amendment (the "Second Amendment") to November 9, 2012. The Agreement, as modified by the First Amendment and the Second Amendment, otherwise remains in full force and effect.
The description of the Second Amendment herein does not purport to be complete and is qualified in its entirety by reference to the Second Amendment, a copy of which is filed as Exhibit 10.5 to this Current Report on Form 8-K and is incorporated herein by reference.
Appointment of Interim President and Chief Executive Officer
On November 2, 2012, the Board appointed David D. Clark, the Company's Executive Vice President of Administration and Chief Financial Officer, as the Company's Interim President and Chief Executive Officer for the period commencing on November 9, 2012, which is the employment cessation date for Mr. Redling, and ending on November 15, 2012, which is the employment commencement date for Ms. Zier. The information required by Items 401(b), (d), (e) and Item 404 (a) of Regulation S-K, as well as a brief description of Mr. Clark's employment agreement, can be found in the Company's annual meeting proxy statement filed with the Securities and Exchange Commission on April 23, 2012 and is incorporated herein by reference.
The Company issued a press release on November 5, 2012 announcing, among other things, the appointment of Mr. Clark as Interim President and Chief Executive Officer, which is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
Exhibit No. Description
10.1 Letter Agreement between Nutrisystem, Inc. and Dawn Zier, dated November 1, 2012.
10.3 Form of Stock Option Agreement for Dawn Zier.
10.4 Form of Performance-Based Restricted Stock Unit Agreement for Dawn Zier.
10.5 Letter Agreement Amendment between Nutrisystem, Inc. and Joseph M. Redling, dated November 1, 2012.
99.1 Press Release, dated November 5, 2012.
Nutrisystem, Inc.
November 1, 2012
Ms. Dawn Zier
[Address redacted]
Dear Dawn:
We are pleased to extend to you an offer to join NutriSystem, Inc. (the "Company") on the terms set forth in this letter agreement (this "Agreement").
Start Date: |
November 15, 2012 |
Title/Reporting: |
Chief Executive Officer ("CEO") and President, reporting solely to the Company's Board of Directors (the "Board"). Executive will devote her full business time and best efforts to the performance of her duties for the Company, provided , however , that Executive shall be able to manage her personal investments or to engage in or serve such civic, community, charitable, educational, or religious organizations as she may select, so long as such service does not create a conflict of interest with, or interfere with the performance of, the Executive's duties hereunder or conflict with the Executive's covenants under the restrictive covenants agreement (attached hereto as Exhibit A ). |
At-Will Employment: |
Executive will be an at-will employee, which means that her employment may be terminated by either the Company or by her at any time, for any reason. Upon any cessation of her employment, except as otherwise provided herein, Executive's entitlement will be limited to the payment of Base Salary accrued but unpaid through the effective date of that cessation, plus any vested benefits payable under the terms of the applicable plans. |
Board Service: |
Executive will be appointed to the Board upon or promptly following her commencement of service, and nominated for re-election so long as actively employed as CEO. Unless otherwise requested by the Board, Executive agrees to voluntarily resign from Board upon any cessation of her employment. |
$600,000, subject to annual review (but not to be decreased below $600,000). |
|
2012 Annual Bonus: |
None |
Benefits/Vacation |
Executive will participate in the same vacation policies and benefit programs as other senior executives of the Company, subject to the terms of those policies and programs as in effect from time to time. |
Minimum 2013 Annual Bonus: |
$250,000, subject to continued employment through the end of the 2013 year (however, Executive's actual 2013 Annual Bonus shall be based on actual performance against objectives and she shall receive a 2013 Annual Bonus based on the program described below, if that yields an amount greater than the Minimum 2013 Annual Bonus). |
Annual Bonus Opportunity for 2013 and later years: |
Target annual bonus will be $500,000 or 75% of then current Base Salary, whichever amount is greater. Actual range of payout will be 0 to 150% of the target, based on actual performance against objectives established by the Compensation Committee (but subject, in the case of 2013, to the minimum bonus described above). Bonuses are paid within two and one-half months following the end of the relevant fiscal year. Except as otherwise provided herein, Executive will be required to remain employed through the applicable bonus payment date in order to receive any bonus. |
2013 Annual Equity Grant: |
Provided she remains employed on the date that 2013 annual equity grants are made to other named executive officers (generally by March 31st), Executive will then receive an annual equity grant in the ordinary course with a grant date fair value of approximately $850,000. The components and terms of that grant will be determined by the Board, in its discretion, and will be substantially consistent with the components and terms of 2013 annual grants made to other named executive officers. Notwithstanding the above, the components of the grant shall consist of at least 25% time-vested restricted shares and 25% time-vested stock options. |
Temporary Housing/Transportation: |
Executive will receive a $4,167/month allowance for transportation and temporary housing costs for two years. |
Replacement Grants |
To compensate Executive for compensation opportunities foregone at her prior employer, Executive will be granted the following awards upon commencement of her employment: (a) $500,000 cash signing bonus, subject to prompt repayment if her employment with the Company ceases before the earlier of the second anniversary of her employment commencement or a Change of Control. (b) Restricted shares under the Company's Amended and Restated 2008 Long Term Incentive Plan (the "LTIP") with a grant date fair value equal to $800,000, subject to time-based vesting over two years in four equal installments, subject to full acceleration upon a Change of Control. |
Inducement Grants: |
To induce Executive to accept this offer and to provide her with an immediate stake in the success of the Company, Executive will be granted the following awards under the LTIP upon commencement of her employment: (a) Stock options with a grant date fair value equal to $300,000, subject to time-based vesting in equal annual installments over four years. (b) Performance-vested RSUs ("PRSUs") with a grant date fair value equal to $300,000. Actual range of payout will be 0 to 150% of target number of shares, based on TSR performance of the Company relative to the Russell 3000 Index for the three year period beginning January 1, 2013 and subject to continued employment through the end of that performance period. |
Severance Rights Upon Termination without Cause, Resignation with Good Reason: |
If Executive's employment ceases due to a termination by the Company without "Cause" or a resignation by the Executive with "Good Reason," she will be entitled to: (a) Continuation of then current Base Salary for two years at customary payroll intervals. (b) Direct payment (if administratively possible) or reimbursement of the portion of the monthly COBRA premium that exceeds the active employee cost of group health coverage for 18 months. (c) A pro-rata portion of her annual bonus for the year of termination, based on actual performance through the end of the year and pro-rated based on the number of days of service completed during that year. (d) Payment of her 2013 minimum annual bonus, to the extent not already paid (or payable pursuant to the preceding bullet). (e) Relief from her obligation to repay the cash signing bonus, if the minimum service requirement is not already satisfied. (f) Full vesting of the replacement restricted stock and inducement stock option grants, if not already vested. (g) If severance occurs prior to settlement of inducement PRSU grant, a pro-rata portion of that PRSU grant, based on actual performance through the end of the performance period and pro-rated based on the number of days of service completed during that performance period. (h) Direct payment to a service provider of Executive's choice of the reasonable costs of 12 months of executive outplacement benefits, up to a maximum of $50,000. These payments and benefits are conditioned on: (1) Executive's execution and delivery to the Company of a general release of claims against the Company and its affiliates, substantially in a form approved by the Board (the "Release"); (2) such Release becoming irrevocable within 30 days following the cessation of Executive's employment; and (3) Executive's continued compliance with her restrictive covenant obligations to the Company. Except for items (c) and (g), these payments and benefits will be paid or provided (or begin to be paid or provided, as applicable) on the first regularly scheduled payroll date that occurs after the Release becomes irrevocable, provided that if the 30 day period described above begins in one taxable year and ends in a second taxable year, such payments or benefits shall not commence until the second taxable year. Items (c) and (g) will be paid within two and one-half months following the end of the applicable performance period. |
Payments upon Executive's death/Disability: |
If Executive's employment ceases due to Executive's death or "Disability," she (or her estate) will be entitled to: (a) A pro-rata portion of her annual bonus for the year of termination, based on actual performance through the end of the year and pro-rated based on the number of days of service completed during that year, payable within two and one-half months following the end of the applicable year. (b) Payment of her 2013 minimum annual bonus within two and one-half months following the end of the applicable year, to the extent not already paid (or payable pursuant to the preceding bullet). (c) Relief from her obligation to repay the cash signing bonus, if the minimum service requirement is not already satisfied. (d) Full vesting of the inducement stock option grant, if not already vested. (e) Vesting of the next tranche of the replacement restricted stock award, if not already fully vested. (f) If such termination of employment occurs prior to settlement of inducement PRSU grant, vesting of a pro-rata portion of the target PRSU grant. If Executive's employment ceases due to Executive suffering a Disability, these payments and benefits will be conditioned on: (1) Executive's execution and delivery to the Company of a Release; (2) such Release becoming irrevocable within 30 days following the cessation of Executive's employment; and (3) Executive's continued compliance with her restrictive covenant obligations to the Company. |
Definitions: |
For purposes of this Agreement: " Cause" means: (a) Executive is convicted of a felony, or (b) in the reasonable determination of the Board, Executive has done any one of the following: (1) committed an act of fraud, embezzlement, or theft in the course of her employment, (2) caused intentional, wrongful damage to the property of the Company, (3) Executive's material breach of any agreement with the Company or its affiliates, any duty owed to the Company or its stockholders or any published policy of the Company, which breach (if curable) is not have cured within 30 days after receiving written notice from the Board specifying the details of the breach, or (4) engaged in gross misconduct or gross negligence in the course of employment. For avoidance of doubt, (x) Executive's unwillingness to relocate her family's permanent residence to any location at the Company's request shall not constitute "Cause," and (y) a termination due to Executive suffering a Disability will not constitute a termination "without Cause." "Change of Control" has the same meaning as defined in the LTIP. "Disability" means a condition entitling Executive to benefits under any long-term disability plan or policy maintained or funded by the Company. "Good Reason" means: (a) a material diminution of Executive's title, authority, duties or responsibilities or a change in Executive's reporting structure described above; (b) a material reduction in Executive's then current Base Salary or annual bonus target opportunity (c) a material change in the geographic location at which the Executive performs services for the Company, which for this purpose shall mean the relocation of the Company's headquarters by more than 50 miles; (d) failure of the Board to appoint Executive as a member of the Board within 30 days following her commencement of employment or to nominate her for re-election upon expiration of any term of her service as a director; and (e) a material breach of this Agreement by the Company; provided that, any such event will constitute Good Reason only if Executive notifies the Company in writing of such event within 90 days following the initial occurrence thereof, the Company fails to cure such event within 30 days after receipt from Executive of written notice thereof, and Executive resigns her employment within 30 days following the expiration of that cure period. |
Restrictive Covenants: |
Executive represents and warrants to the Company that there are no orders, judgments, decrees, restrictions, agreements or understandings by which she is bound that would prevent or make unlawful her execution of this Agreement, that would be inconsistent or in conflict with this Agreement or her obligations hereunder, or that would otherwise prevent, limit or impair the performance her duties to the Company. As a condition of her employment, Executive is required to execute the restrictive covenant agreement attached hereto as Exhibit A . |
Section 409A: |
Notwithstanding anything herein to the contrary, to the extent compliance with the requirements of Treas. Reg. Section 1.409A-3(i)(2) (or any successor provision) is necessary to avoid the application of an additional tax under Section 409A of the Internal Revenue Code ("Section 409A") to any payments due to Executive upon or following her Separation from Service (within the meaning of Treas. Reg. Section 1.409A-1(h)(1) or any successor provision)), then notwithstanding any other provision of this Agreement (or any otherwise applicable plan, policy, agreement or arrangement), any such payments that are otherwise due within six months following Executive's Separation from Service will be deferred without interest and paid to Executive in a lump sum immediately following that six month period. This paragraph should not be construed to prevent the application of Treas. Reg. Sections 1.409A-1(b)(4) or -1(b)(9)(iii)(or any successor provisions) to amounts payable to the Executive. For purposes of the application of Treas. Reg. Section 1.409A-1(b)(4) (or any successor provision) to amounts payable hereunder, each payment in a series of payments will be deemed a separate payment. While the parties have endeavored to structure Executive's compensation rights so that payments to her are exempt from or compliant with Section 409A, the Company makes no representation to Executive in this regard and will have no obligation to indemnify Executive for taxes or interest imposed under Section 409A. |
Indemnification |
The Company shall indemnify and hold Executive harmless for and against any and all costs, expenses, liabilities, losses, fees (including without limitation attorneys' and/or other professional fees, disbursements and charges), awards, judgments, penalties, fines, verdicts, taxes, penalties, sanctions and interests, arising out of any and all acts and/or omissions, or claimed acts and/or omissions, in her capacity as an officer, director, manager, agent, representative, member and/or employee of the Company, to the maximum extent permitted under the greater of (a) any Company corporate governance document (such as a bylaw or articles of incorporation); or (b) applicable law. Executive shall further be entitled to a prompt advancement of any and all reasonable costs, expenses, disbursements, and fees (including without limitation attorneys' and/or other professional fees, disbursements and charges) incurred or to be incurred by her in connection with an actual or threatened civil, criminal, regulatory, arbitral, governmental, administrative and/or other action of other proceeding, or investigation, arising out of any and all acts and/or omissions, or claimed acts and/or omissions, in her capacity as an officer, director, manager, agent, representative, member and/or employee of the Company, subject to her execution of an undertaking to repay such advances if her conduct is later determined not to have met the standard required for indemnification of such amounts and subject further to any other requirement or condition imposed by applicable law. |
Other: |
(a) Within 30 days following the execution of this Agreement, the Company shall directly pay to Executive's attorneys (Outten & Golden LLP) for reasonable legal fees incurred in the documentation of these arrangements, up to a maximum of $15,000. (b) Executive will be subject to all corporate policies applicable to executive officers and directors, including securities trading policy, anti-hedging policy, clawback policy and stock ownership guidelines. (c) All payments (or transfers of property) to Executive will be subject to tax withholding to the extent required by applicable law. (d) Both during and following her service with the Company, Executive agrees to cooperate with the Company in connection with any action or proceeding (or any appeal from any action or proceeding) that relates to events occurring during Executive's employment by the Company. After Executive's employment ceases, the Company will provide reasonable advance notice of its need for Executive's cooperation and will attempt to schedule and limit the need for Executive's cooperation so as to minimize any disruption of Executive's personal and other professional obligations. The Company will reimburse Executive, in accordance with the Company's policy, for reasonable out of pocket travel and other expenses that she incurs as a result of her cooperation. (e) In advance of any reasonably foreseeable event or transaction described in Treas. Reg. Section 280G-1, Q/A-2(a)(3)(i), (ii) or (iii), the Company and Executive will cooperate and exercise commercially reasonable efforts to engage in lawful planning to seek to minimize adverse tax consequences on either of them under Sections 280G and 4999 of the Internal Revenue Code. For avoidance of doubt, however, this paragraph does not obligate the Company to pay any additional amount to Executive or reimburse Executive for any taxes payable by her. (f) Notices permitted or required under this Agreement shall be in writing and shall be deemed to have been duly given when delivered by hand or overnight courier addressed, in the case of the Company, c/o its General Counsel as its principal executive office and, in the case of Executive, to her most recent address set forth in the personnel records of the Company. (g) This Agreement shall inure to the benefit of, and shall be binding upon, the parties, their heirs, executors, administrators, agents, assigns, and estates, provided that Executive's rights and obligations under this Agreement are personal to her and may not be assigned. (h) This Agreement is governed by Pennsylvania law, without regard to the principles of conflicts of laws. Any disputes, actions, claims or causes of action arising out of or in connection with this Agreement or the employment relationship between the Company and Executive shall be subject to the exclusive jurisdiction of the United States District Court for the Eastern District of Pennsylvania or the Pennsylvania state courts located in Montgomery County. (i) This Agreement sets forth the parties' entire agreement regarding Executive's employment and compensation by the Company and supersedes all prior agreements, discussions and understandings on those topics. This Agreement may not be modified in any way except by a written amendment executed by Executive and a duly authorized representative of the Company. |
Your signature below confirms that all information provided to us during the interview and hiring process is true and accurate in all material respects. To indicate your acceptance of our offer and its terms, please sign and date the Agreement in the space provided below and return it to me. Please retain a copy for your records.
Sincerely,
/s/ David D. Clark
David D. Clark
Executive Vice President of Administration,
Chief Financial Officer and Treasurer
Agreed and accepted on November 1, 2012:
By: /s/ Dawn M. Zier __
Dawn Zier
NUTRISYSTEM, INC.
AMENDED AND RESTATED NUTRISYSTEM, INC.
2008 LONG-TERM INCENTIVE PLAN
STOCK AWARD AGREEMENT
Dawn Zier
This STOCK AWARD AGREEMENT, dated as of November __, 2012 (the " Date of Grant "), is delivered by NutriSystem, Inc. (the " Company ") to Dawn Zier (the " Grantee ").
RECITALS
A. The Amended and Restated NutriSystem, Inc. 2008 Long-Term Incentive Plan (the " Plan ") permits the grant of stock awards in accordance with the terms and conditions of the Plan.
B. In satisfaction of the Company's commitment to issue restricted shares to the Grantee upon commencement of her employment, as contained in the letter agreement between the Employer and the Grantee dated November 1, 2012 (the " Employment Agreement "), the Compensation Committee of the Board of Directors of the Company (the " Committee ") has approved this stock award.
NOW, THEREFORE, the parties to this Agreement, intending to be legally bound hereby, agree as follows:
(i) 25% of the shares subject to the Restricted Stock shall become vested six months following the Date of Grant;
(ii) 25% of the shares subject to the Restricted Stock shall become vested on the first anniversary of the Date of Grant;
(iii) 25% of the shares subject to the Restricted Stock shall become vested eighteenth months following the Date of Grant; and
(iv) the remaining 25% of the shares subject to the Restricted Stock shall become vested on the second anniversary of the Date of Grant.
The vesting of the shares subject to the Restricted Stock shall be cumulative, but shall not exceed 100% of the shares subject to the Restricted Stock. If the foregoing schedule would produce fractional shares, the number of shares that vest shall be rounded down to the nearest whole share.
IN WITNESS WHEREOF, the Company has caused its duly authorized officer to execute this Agreement, and the Grantee has placed his or her signature hereon, on this __ day of November, 2012.
NUTRISYSTEM, INC.
Attest:
By:
Name: Kathleen Simone Name: David Clark
Title: SVP, Finance & Controller Title: Chief Financial Officer
I hereby accept the grant of Restricted Stock described in this Agreement, and I agree to be bound by the terms of the Plan and this Agreement. I hereby further agree that all of the decisions and determinations of the Committee shall be final and binding.
Grantee: Dawn Zier
NUTRISYSTEM, INC.
2008 LONG-TERM INCENTIVE PLAN
NONQUALIFIED STOCK OPTION GRANT
Dawn Zier
This NONQUALIFIED STOCK OPTION GRANT AGREEMENT (the " Agreement "), dated as of November __, 2012 (the " Date of Grant "), is delivered by NutriSystem, Inc. (the " Company ") to Dawn Zier (the " Grantee ").
RECITALS
A. The Amended and Restated NutriSystem, Inc. 2008 Long-Term Incentive Plan (the " Plan ") permits the grant of stock options to purchase shares of common stock of the Company, par value $0.001 per share (" Company Stock ").
B. In satisfaction of the Company's commitment to issue stock options to the Grantee upon commencement of her employment, as contained in the letter agreement between the Employer and the Grantee dated November 1, 2012 (the " Employment Agreement "), the Compensation Committee of the Board of Directors of the Company (the " Committee ") has approved this grant.
NOW, THEREFORE, the parties to this Agreement, intending to be legally bound hereby, agree as follows:
Vesting Date |
Portion of Option Becoming Exercisable on the Vesting Date
|
First Anniversary of Date of Grant |
25% |
Second Anniversary of Date of Grant |
25% |
Third Anniversary of Date of Grant |
25% |
Fourth Anniversary of Date of Grant |
25% |
The vesting and exercisability of the Option is cumulative, but shall not exceed 100% of the shares of Company Stock subject to the Option. If the foregoing schedule would produce fractional shares of Company Stock, the number of shares of Company Stock for which the Option becomes vested and exercisable shall be rounded down to the nearest whole share.
Notwithstanding the foregoing, in no event may the Option be exercised after the date that is immediately before the seventh anniversary of the Date of Grant. Any portion of the Option that is not exercisable at the time the Grantee ceases to be employed by, or provide service to, the Employer (determined after giving effect to Paragraph 2(b) or 2(c), if applicable) shall immediately terminate.
IN WITNESS WHEREOF, the Company has caused its duly authorized officer to execute this Agreement, and the Grantee has placed his or her signature hereon, on this ___ day of November, 2012.
NUTRISYSTEM, INC.
Attest:
By:
Name: Kathleen Simone Name: David Clark
Title: SVP, Finance & Controller Title: Chief Financial Officer
I hereby accept the grant of the Option described in this Agreement, and I agree to be bound by the terms of the Plan and this Agreement. I hereby further agree that all of the decisions and determinations of the Committee shall be final and binding.
Grantee: Dawn Zier
NUTRISYSTEM, INC.
AMENDED AND RESTATED NUTRISYSTEM, INC.
2008 LONG-TERM INCENTIVE PLAN
PERFORMANCE-BASED RESTRICTED STOCK UNIT GRANT
Dawn Zier
This PERFORMANCE-BASED RESTRICTED STOCK UNIT GRANT (this " Grant "), dated as of November __, 2012 (the " Date of Grant "), is delivered by NutriSystem, Inc. (the " Company ") to Dawn Zier (the " Grantee ").
RECITALS
A. The Amended and Restated NutriSystem, Inc. 2008 Long-Term Incentive Plan (the " Plan ") permits the grant of performance-based restricted stock units that are convertible into an equivalent number of shares of common stock of the Company, par value $0.001 per share (the " Company Stock "), with the total number of performance-based restricted stock units that may be earned and converted into shares of Company Stock conditioned on the achievement of specified performance goals and vesting conditions.
B. In satisfaction of the Company's commitment to issue performance-based restricted stock units to the Grantee upon commencement of her employment, as contained in the letter agreement between the Employer and the Grantee dated November 1, 2012 (the " Employment Agreement "), the Compensation Committee (the " Committee ") of the Board of Directors of the Company (the " Board ") has approved this Grant.
NOW, THEREFORE, the parties to this Grant, intending to be legally bound hereby, agree as follows:
[Remainder of page intentionally left blank; signature page follows]
IN WITNESS WHEREOF, the Company has caused its duly authorized officer to execute and attest this instrument, and the Grantee has placed his or her signature hereon, on this ___ day of November, 2012.
Attest: |
NUTRISYSTEM, INC. |
By:__________________________________ |
By:__________________________________ |
Name: Kathleen Simone |
Name: David D. Clark |
Title: SVP, Finance & Controller |
Title: Chief Financial Officer |
I hereby accept the grant of Performance Units described in this Grant, and I agree to be bound by the terms of the Plan and this Grant. I hereby further agree that all of the decisions and determinations of the Committee shall be final and binding.
__________________________________
Grantee: Dawn Zier
EXHIBIT A
PERFORMANCE GOALS
The performance measure applicable to the award of PRSUs shall be based on the Company's Total Shareholder Return ("TSR") over the three year Performance Period relative to the TSR of the Russell 3000 Index for the same Performance Period. For these purposes, the TSR shall be determined based on the change in the stock price of, and the dividends and distributions paid by, the relevant entity during the Performance Period. At the end of the Performance Period, the Company's TSR performance relative to the TSR performance of the companies in the Russell 3000 Index shall be determined and the PRSUs shall vest and become payable, if at all, based on the following schedule:
Company's Relative TSR Performance |
Vesting as a Percentage of the Target Award |
Less than 35 th percentile |
0% |
35 th percentile |
50% |
50 th percentile |
100% |
85 th percentile or greater |
150% |
If the Company's relative TSR results for the Performance Period are either (a) between the 35 th percentile and the 50 th percentile or (b) between the 50 th percentile and the 85 th percentile, then, in either such case, the percentage of the Target Award that shall become vested and payable shall be determined by linear interpolation.
NutriSystem, Inc.
600 Office Center Drive
Ft. Washington, PA 19034
November 1, 2012
Via Hand Delivery
Mr. Joseph M. Redling
Dear Joe:
Reference is hereby made to the letter agreement between us dated April 4, 2012 and amended on September 27, 2012 (the "Amended Letter Agreement"). As you know, the Amended Letter Agreement contemplated the cessation of your service to the Company on the "Cessation Date," which term was defined as November 2, 2012 or such earlier date requested by the Company on 15 days prior written notice. To enable the Company to complete the hiring process for its new Chief Executive Officer , you have agreed to extend the Cessation Date to November 9, 2012.
On the Cessation Date, as redefined by this letter, your service to the Company will cease on the terms described in the Amended Letter Agreement; provided that, the date "November 2, 2012" in the second sentence of the fourth paragraph of the Amended Letter Agreement is hereby replaced with "November 9, 2012."
To confirm that this letter accurately reflects our agreement, please countersign it in the space provided below and return it to me.
Sincerely,
/s/ David D. Clark
David D. Clark
Executive Vice President & CFO
Agreed on this 1 st day of November, 2012:
/s/ Joseph M. Redling ___________
FOR IMMEDIATE RELEASE
Contacts:
Investors
Joe Crivelli
Gregory FCA
Direct: 610-228-2100
Media
Tricia Primrose
Impression Partners
Direct: 917-679-9585
DAWN M. ZIER TO JOIN NUTRISYSTEM AS PRESIDENT AND CHIEF EXECUTIVE OFFICER
Reader's Digest veteran brings analytics-driven multi-channel marketing approach, turnaround and leadership skills to the top job at Nutrisystem
Fort Washington, Pa.-November 5, 2012- Nutrisystem, Inc. (NASDAQ: NTRI), a leading provider of weight management products and services, today announced that Dawn M. Zier will join the company as president and chief executive officer. She will also serve on the Nutrisystem board of directors. She replaces Joe Redling, who is stepping down as president and chief executive officer and resigning from the company's board of directors.
Ms. Zier is a 20-year veteran of Reader's Digest Association, Inc., a leading global, multi-brand and multi-platform media and direct marketing company. At Reader's Digest, she served in a range of leadership positions across the United States and internationally, most recently as president of the company's international business, with responsibility for $750 million of revenue and a team of 1,000 employees across Europe, Asia Pacific, and Latin America.
While at Reader's Digest, Ms. Zier established a consumer-centric and affinity marketing model, developing new product offerings and marketing strategies specifically targeted to the demographics and psychographics of key groups of customers and prospects. She has a strong track record of driving growth across the food affinity and digital channels. As president of the international business, she has been actively building the company's portfolio of licensing arrangements in countries outside the U.S., while significantly reducing operating costs. She is a respected thought leader in the direct marketing business, and has served on the board of directors of the Direct Marketing Association since 2008.
Mike Hagan, chairman of the Nutrisystem board of directors stated, "We're excited to announce the appointment of Dawn Zier as Nutrisystem's next president and chief executive officer. Dawn's experience and accomplishments fit our requirements perfectly, as she has led Reader's Digest Association's transformation to a customer-centric business model, built new products and developed new revenue streams in the digital arena, and demonstrated a clear ability to manage costs and drive efficiencies to deliver strong financial results. We believe that she will be a powerful agent for change, and we look forward to her contributions, perspective, and leadership at Nutrisystem."
Dawn Zier added, "Joining Nutrisystem is a wonderful opportunity for me personally, and the logical next step in my career. The company has a strong portfolio of products that help consumers lose weight, improve their health, and live better lives. It has significant name recognition as a result of several decades of marketing investment in the brand. And it's universally seen as one of the leaders in the weight loss sector. With a fresh and creative approach to the consumer, a thoughtful eye to new product development, and a careful effort to contain costs, I believe we can improve financial performance and build shareholder value. I look forward to working with Mike Hagan, the board of directors, and the entire Nutrisystem team to make this happen."
Ms. Zier holds a Master of Business Administration degree from the MIT Sloan School of Management, as well as a Master of Science degree in electrical engineering and computer science from MIT. She received her Bachelor of Engineering degree from the State University of New York at Stony Brook.
Ms. Zier will join Nutrisystem on November 15, 2012. Joe Redling will remain with the company as chief executive officer through disclosure of the company's third quarter financial results on November 9, 2012. David Clark, the company's chief financial officer, will serve as interim chief executive officer between Mr. Redling's departure date and Ms. Zier's arrival at the company.
About Nutrisystem
Having helped Americans lose millions of pounds over the last 40 years, Nutrisystem, Inc. (NASDAQ: NTRI) develops evidence-based programs for healthy weight management, and is the leading provider of home-delivered weight loss meal plans. Nutrisystem offers balanced nutrition in the form of low glycemic index meal plans designed for men and women, including seniors, vegetarians and the Nutrisystem® D® program for people with diabetes or at risk for type 2 diabetes. Nutrisystem® plans include a wide variety of pantry and fresh-frozen entrees and snacks to aid in program satisfaction and adherence, as well as transition plans to support long-term success. The Fort Washington, PA-based company also provides weight management support and counseling by trained weight-loss coaches and registered dietitians, as well as through an engaged online community, online tools and trackers, mobile apps, cookbooks and more. Healthcare professionals may learn more about the programs by visiting www.nutrisystem.com/hcp. Nutrisystem® weight loss plans are available directly to consumers through www.nutrisystem.com, by phone (1-800-435-4074) and at select retailers. The Company has also introduced a new in-store retail line, Nutrisystem® Everyday™ products, comprised of nutritionally balanced bars, smoothies, bakery and breakfast items aimed at consumers who aspire to eat healthier.
Forward-Looking Statement Disclaimer
This press release may contain forward-looking statements that are made pursuant to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements regarding Nutrisystem's growth plans and other statements that are not statements of historical fact constitute forward-looking statements. These forward-looking statements involve a number of risks and uncertainties, which are described in Nutrisystem, Inc.'s Annual Report on Form 10-K and its other filings with the Securities and Exchange Commission. The actual results may differ materially from any forward-looking statements due to such risks and uncertainties. Nutrisystem, Inc. undertakes no obligation to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.